Nov 10 (Reuters)-
Fuji Pharmaceutical Co Ltd
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Sep 30, 2017 Sep 30, 2016 Sep 30, 2018 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 32.99 31.99 35.69 17.89
(+3.1 pct) (+8.5 pct) (+8.2 pct) (+10.8 pct)
Operating 4.14 3.53
(+17.1 pct) (+5.9 pct)
Recurring 4.48 3.22 4.53 2.44
(+39.3 pct) (+1.0 pct) (+1.2 pct) (+0.2 pct)
Net 3.24 2.15 3.25 1.74
(+50.7 pct) (-5.3 pct) (+0.5 pct) (+0.2 pct)
EPS 216.19 yen 143.51 yen 217.18 yen 116.28 yen
Ann Div 48.00 yen 45.00 yen 56.00 yen
-Q2 Div 23.00 yen 21.00 yen 28.00 yen
-Q4 Div 25.00 yen 24.00 yen 28.00 yen
NOTE - Fuji Pharmaceutical Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T
((Tokyo Headline News Desk +813 6441 1812))